Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1431-1440 of 2787 for cancer

Edit search filters
  1. A Study to Assess AC220 Given in Combination with Induction and Consolidation Therapy for Newly Diagnosed Acute Myeloid Leukemia (AML)

    Jacksonville, FL

  2. A Trial to Find and Investigate a Safe Dose of BI 836858 in Combination With Decitabine for Patients With Acute Myeloid Leukemia (AML)

    Jacksonville, FL

  3. WISP (Women Choosing Surgical Prevention)

    Rochester, MN

  4. Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients

    Rochester, MN

  5. A Study of Ovarian Tissue Freezing for the Preservation of Fertility in Children

    Rochester, MN

  6. Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma

    Rochester, MN

  7. ACP-196 in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies

    Rochester, MN, Jacksonville, FL

  8. Dinaciclib, Bortezomib, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Phase 3 Study to Treat Patients with Soft Tissue Sarcomas

    Jacksonville, FL, Rochester, MN

  10. Phase 1 Dose Finding Study of Belinostat for Treatment of Patients With Peripheral T-cell Lymphoma (PTCL)

    Rochester, MN

.

Mayo Clinic Footer